July 31, 2013

Rheonix to Advance Automated Diagnostic Testing Technology through Strategic Partnership

ITHACA, N.Y. – Rheonix, Inc., a developer of fully automated molecular testing solutions, and Life Technologies Corp. (NASDAQ: LIFE), a global leader in the life sciences tools and diagnostic markets, have entered into a joint development agreement to introduce a molecular testing platform for their Applied Markets business. Technology developed by Rheonix for the molecular diagnostics market, including the Rheonix CARD® , a disposable cartridge the size of a credit card… Read More »